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ABSTRACT
The origins of replication of p29 DNA have been studied by
analyzing the activity as templates in the 029 in vitro replica-
tion system of E. coli recombinant plasmids and M13 derivatives
containing 029 DNA terminal sequences. Plasmid pITR, containing
the 6 bp long inverted terminal repeat of 929 DNA, was shown to
be essentially inactive. The analysis of a series of deletion
derivatives of plasmid pID13, that contains the 73 and 269 bp
from the left and right 029 DNA ends, respectively, indicated
that the minimal origins of replication are comprised within the
terminal 12 bp at each DNA end. Point site-directed and random
mutagenesis at these sequences was carried out. Changes of the
second or third A into a C completely abolished the template
activity. In the case of changes at position from 4 to 12, only 3
out of 14 mutations reduced the template activity; these 3 muta-
tions were double changes and 2 of them affected the inverted
terminal repeat. The results suggest that the sequence require-
ment at the end-proximal region of the origin of replication is
more strict than that at the distal region.
INTRODUCTION
The Bacillus subtilis phage i29 has a linear, double-
stranded DNA genome, 19,285 bp long (1), with an inverted termi-
nal repeat (ITR) 6 bp long and a viral-coded protein covalently
linked to each 5' end (2). i29 DNA replication starts at either
DNA end and proceeds by a mechanism of strand displacement (3,4).
Two copies of the terminal protein p3 are involved in the initia-
tion step of #29 DNA replication at two different levels: a) A
newly synthesized molecule of protein p3 acts as a primer of
replication: the hydroxyl group of a specific serine residue (5),
is used by the viral-encoded DNA polymerase, protein p2, to
incorporate the first nucleotide of the nascent chain, dAMP (6).
b) The p3 molecule linked to 929 DNA, named parental terminal
protein, plays an important role as a structural part of the
template (7,8), probably by setting a direct interaction with the
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priming protein p3 (9). However, the specificity of the template
is determined not only by the parental terminal protein. We have
recently shown that protein-free terminal fragments of 029 DNA
are active templates for the formation of the initiation complex
p3-dAMP in an in vitro system with purified proteins p2 and p3
(10), indicating that specific base sequences may function as
origins of replication. Furthermore, the DNA of pID13, an E. coli
recombinant plasmid containing the terminal 73 bp from the left
029 DNA end and the terminal 269 bp from the right end, is also
an active template in the in vitro initiation reaction, provided
it has been previously digested with the restriction endonuclease
DraI to release the cloned i29 terminal sequences at DNA ends
(11). The template activity is lower than that of 029 DNA with
the parental terminal protein, but the initiation site is the
correct one, at the very end of the DNA, and full replication of
the p29-specific restriction fragments can take place.
The availability of plasmid pID13 enabled us to study in
more detail the template requirements of the 029 protein-priming
reaction. Here we report the production of deleted and point-
mutated derivatives of cloned terminal sequences of 029 DNA and
their activity as origins of replication in the 929 in vitro
system.
MATERIALS AND METHODS
Bacterial strains and cloning vectors. The recombinant plasmid
pID13, containing the ends of 029 DNA, has been described
elsewhere (11). The E. coli strain W3110 lac Iq (12), used as
host for the plasmid vector pKK223-3 (13) and its derivatives,
was obtained from J. Alonso. The E. coli strains JM103 (14) and
JM109 (15) were used as hosts for derivatives from phages M13 mp8
(16) and M13 mpl9 (17), respectively. Competent cells of each E.
coli strain were prepared as described by Hanahan (18).
Nucleoside triphosphates and enzymes. (y-32P)ATP (-3000 Ci/mmol),
( a-35S)dATP (-600 Ci/mmol) and (-32P)dATP (.410 Ci/mmol) were
from the Radiochemical Centre (Amersham). ATP and deoxynucleoside
triphosphates were from P-L Biochemicals.
Restriction nucleases were from New England Biolabs,
Boehringer Mannheim and Amersham, and were used according to the
three-buffers system of Maniatis et al. (19). Klenow fragment of
E. coli DNA polymerase I and exonuclease Bal 31 were from New
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England Biolabs; mung bean nuclease from P-L Biochemicals and
exonuclease III, from Bethesda Research Laboratories, were used
according to the directions of Stratagene, cloning systems. All
other enzymes were from Boehringer, and were used according to
the supplier.
DNA manipulations. Plasmid DNAs and the replicative form of phage
M13 DNA and its derivatives were isolated as described by Clewell
and Helinski (20). The single-stranded form of M13 DNA and its
derivatives was prepared as described by Sanger et al. (21). For
analysis, plasmid DNA was prepared as described by Birnboim and
Doly (22).
Deletion derivatives of plasmid pID13 (see Fig. 2) were
first prepared by linearizing 10 pg of plasmid pID13 with SalI or
HindIII, next to the cloned left or right 029 DNA ends, respec-
tively. The DNA was precipitated with ethanol and resuspended in
50 pl of the Bal 31 buffer recommended by the supplier. Two units
of this enzyme were added and the samples were incubated at 300C
for 14 min. Samples of 5 pl were taken each minute, beginning at
the 5th minute of incubation, and stopped with EGTA. One half of
each sample was treated with a second restriction enzyme and
analyzed in 1% agarose gels. The remainder of those samples
containing DNAs appropriately degraded was ethanol-precipitated,
treated with Klenow fragment for 30 min at room temperature and
with T4 DNA ligase overnight at 150C. The DNA was then used to
transform W3110 lac Iq competent cells and transformants were
screened by restriction and sequence analysis.
Exonuclease III and mung bean nuclease were also used to
generate deletions in pDA59, one of the Bal 31 derivatives of
pID13. About 6 pg of plasmid pD&59 were linearized with StuI, the
DNA was ethanol-precipitated and resuspended in 40 pl of 10 mM
Tris-HCl, pH 8, and 1 mM EDTA (TE buffer); 50 p1 of the 2x exonu-
clease III buffer and 5 p1 of 0.4 M B-mercaptoethanol were added
and the mixture was warmed at 25°C for 1 min. Approximately 50
units of exonuclease III were added and samples of 33 pl were
taken after 45, 75 and 105 sec of incubation. The three samples
were then joined, adjusted to the mung bean nuclease buffer, and
further incubated with this enzyme for 1 h at 300C. The mixture
was phenol-extracted and the DNA was digested with SalI,
releasing the target i29 DNA sequence in fragments ranging in
size from about 300 to 400 bp. These fragments were isolated by
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polyacrylamide gel electrophoresis in a buffer containing 0.1 M
Tris- borate, pH 8.3, 2 mM EDTA (TBE), extracted from the gel by
electroelution and coprecipitated with the SalI/SmaI-cut replica-
tive form of the DNA of phage 113 mpl9, and ligated overnight.
The ligation mixture was used to transform E. coli JM109 compe-
tent cells and those transformants giving a white plaque were
screened by sequence analysis.
The 17-mers used to generate a synthetic linker with the 929
ITR sequences and the 24-mers used to change the 2nd or the 3rd
position at the cloned 929 DNA ends were a gift of Antibioticos,
S.A. The 32-mers mixture containing point mutations in the 029
origins of replication was prepared in a 380A Synthesizer of
Applied Biosystems. All synthetic oligonucleotides were purified
by polyacrylamide gel electrophoresis as recommended by Applied
Biosystems.
Point mutants at the 2nd or 3rd positions of 929 DNA
terminal sequences subcloned in phage M13 mp8 DNA were prepared
by the directed mutagenesis procedure described by Zoller and
Smith (23). Two synthetic 24-mers were used as mutagens for the
single-stranded DNA of clone G7, which is an M13 mp8 derivative
containing the wild-type sequences of the 73 and the 125 terminal
bp from the left and right 929 DNA ends, respectively. The muta-
genic readtion was carried out with both oligonucleotides mixed,
and the DNAs of the resultant mutants were separately screened on
nitrocellulose filters with a radioactive probe of each one.
The saturation mutagenesis method described by Derbyshire et
al. (24) was used to prepare DNA molecules containing point muta-
tions randomly distributed along the terminal 12 bp of each 929
DNA end. A mixture of synthetic oligonucleotides was prepared
using mixed stocks of monomers, each one containing 1/48 parts of
each of the other three. The canonical sequence, showed in Fig.
6A, consisted of both 929 origins of replication joined head to
head and two tails cohesive with XmaI and PstI sites, respective-
ly. The expected frequency of wild-type sequences would be about
21%; the frequency of single, double and triple point mutations,
randomly distributed between the restriction tails, was expected
to be about 73%; quadruple and higher mutations would reach a 6%.
The mixture of oligonucleotides was inserted in phage M13 mpl9
DNA, the DNA was used to transform competent JM109 cells and
mutants were selected by sequence analysis of the transformants.
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The DNA fragments to be tested in the replication assays
were isolated by electrophoresis in gels containing 3.5% poly-
acrylamide in TBE, and extracted from the gel and purified as
described (25).
DNA sequencing was carried out by the chemical method (26)
on pKK223-3 derivatives and by the enzymatic method (27) on M13
derivatives.
Assays for the formation of protein p3-dAMP initiation complex
and for protein p3-primed DNA replication. The incubation mixture
for the initiation reaction contained, in 25 pl, 50 mM Tris-HCl,
pH 7.5, 10 mM MgCl2, 1 mM DTT, 1 mM spermidine, 20 mM (NH4)2So4,
0.25 pM (a-32P) dATP (2.5 pCi), purified proteins p2 (6) and p3
(28) as indicated and the DNA fragments indicated in each case as
templates (3-12 fmol). After incubation for 10 min at 300C, the
reaction was stopped by addition of EDTA to 10 mM and heating for
10 min at 680C and the samples were treated with micrococcal
nuclease. The unreacted (-32P)dATP was removed by filtration
through a Sephadex G-50 spun column in the presence of 0.1% SDS
and the samples were subjected to SDS-polyacrylamide gel electro-
phoresis as described (29). The 32P-labelled p3-dAMP was detected
by autoradiography of the dried gel.
Those initiation assays carried out with DNA templates
lacking a fully active #29 origin of replication gave rise to a
background amount of p3-dAMP initiation complex. As this complex
turned out to elongate very inefficiently, the p3-primed replica-
tion assay was systematically carried out with all DNAs to check
the results obtained in the initiation assays. For the DNA
replication reaction, the incubation mixture was as described
above except that it contained 10 pM (-32P)dATP (2.5 pCi) and 20
p.M each dGTP, dCTP and dTTP. After incubation at 300C, the reac-
tion was stopped by addition of EDTA to 10 mM and SDS to 0.1% and
heating at 680C for 10 min. The unincorporated (a-32P)dATP was
removed from the samples as described for the initiation assay
and the labelled DNA was subjected to electrophoresis in 1%
agarose gels after digestion with proteinase K; the gels were
dried and autoradiographed.
RESULTS
Cloning and template activity of the 029 ITR sequences. To test
the possibility that the 6 bp long ITR of i29 DNA was the minimal
origin of replication, two complementary oligonucleotides 17
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Figure 1. Cloning and template activity of the 929 ITR sequences.
A) 10 pg of each oligonucleotide, in 10 p1, were phosphory-
lated with ATP and polynucleotide kinase. EDTA to 10 mM was added
and the samples were mixed and heated at 90°C for 2 min; NaCl to
50 mM was added and the mixture was placed at 550C and allowed to
cool down slowly to 40C, to facilitate hybridization. Plasmid
pKK223-3 was cut with EcoRI and HindIII and the large DNA frag-
ment was isolated by agarose gel electrophoresis and ligated in
different ratios to the hybridized oligonucleotides, to produce
the recombinant plasmid pITR.T , Dra I sites. B) 19 ng of each
restriction mixture, pID13/DraI (a), pITR/DraI (b), or pKK223-3/
DraI (c), were used as templates in an initiation assay with 6 ng
of protein p2 and 86 ng of protein p3, in the conditions descri-
bed in Materials and Methods, except that the incubation time was
20 min. The position of the initiation complex p3-dAMP is
indicated. C) 19 ng of the restriction mixtures pID13/DraI (a,b)
or pITR/DraI (c,d) were used as templates in a replication assay
with 6 ng of protein p2 in the presence (b,d) or in the absence
(a,c) of 86 ng of protein p3, as described in Materials and
Methods. The positions of the input DNA fragments are indicated.
5900
Nucleic Acids Research
The sizes of the pID13/DraI A, B and c fragments are 2,956, 993
and 692 bp, respectively, and those of the pITR/DraI fragments
are 3,114, 729 and 692 bp, respectively. The label along lane (b)
not coinciding with input fragments is considered to be caused by
single-stranded intermediates of p29-specific replication, asjudged by nuclease Sl sensitivity.
bases long were prepared containing the sequences of two copies
of the 029 ITRs, joined head to head, and tails cohesive with
EcoRI and HindIII restriction sites, respectively (Fig. 1A). The
17-mers were hybridized to one another and ligated to the EcoRI/
Hind III linearized DNA of plasmid pKK223-3. The ligation mixture
was used to transform competent W3110 lac 1q cells. Recombinant
plasmid pITR was identified among transformants by restriction
and sequence analysis.
Treatment of pITR with the restriction nuclease DraI
releases 4 DNA fragments. Each one of the largest fragments, A
and B, 3,114 and 729 bp long, respectively, contains one copy of
the P29 ITR. Besides, the sequence flanking the ITR in fragment A
is identical to that at the right 929 DNA end up to position 7,
and the sequence flanking the ITR in fragment B is identical to
that at the left 929 DNA end up to position 9 (see Fig. 4). Fig.
1B shows that the use of this plasmid after treatment with DraI
as template in the in vitro initiation assay, gave rise to the
formation of a very small amount of p3-dAMP initiation complex
(lane b) as compared to the DraI-treated plasmid pID13, contai-
ning 73 and 269 bp from the left and right 029 DNA ends, respec-
tively (lane a). The template activity of the DraI-cut pITR was
only slightly higher than the background given by the DraI-cut
vector pKK223-3, which lacks W29 DNA sequences (lane c).
Similar results were obtained in the replication assay (Fig.
1C). DraI fragments A and B of plasmid pITR, each containing the
6 bp long ITR of 029 DNA, showed little protein p3-dependent
incorporation of label (lanes c and d), whereas the pID13/Dra I
fragments A and B, containing the left and right 029 DNA ends,
32
respectively, specifically incorporated (a-- P)dATP label in the
presence (lane b), but not in the absence (lane a) of the priming
protein p3. The 692 bp long DraI fragment, without i29 DNA
sequences (fragment C), from the vector regions of both plasmids,
pID13 and pITR, did not replicate, as expected.
These results indicated that the 929 ITRs do not contain all
the sequences needed to function as 029 origins of replication.
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Figure 2. Production and template activity of Bal 31 deletions of
Plasmi-c pID13.
A) The SalI- or the HindIII- linearized plasmid pID13 was
digested with exonuclease Bal 31 to progressively shorten the
left or the right cloned ends of 029 DNA. 029 DNA inserts in the
figure are indicated with double line and the products of the
action of Bal 31 with discontinuous line. The 6 bp long ITR
sequences are represented by striped double-line. t , DraI sites.
B) 34 ng of each DraI fragment containing the left %29 DNA end,
isolated from plasmids pID13 (a), pIM46 (b), or pIA12 (c), were
used as templates in an initiation assay as described in Fig. 1B.
Eight ng of the 692 bp long DraI fragment of pID13, without 929
DNA sequences, were also used as a negative control (d).
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Taking into account the sequences present in pITR, these origins
seemed to extend beyond position 9 at the left 029 DNA end and
beyond position 7 at the right end.
Production and template activity of pID13 deletion derivatives.
Exonuclease Bal 31 was used on linearized plasmid pID13 to obtain
two series of pID13 derivatives with partially deleted left or
right terminal sequences of 029 DNA (Fig. 2A). Two clones were
selected, pIM46 and pIA12, that contained only 46 and 12 bp from
the left 029 DNA end, respectively, as indicated in their name.
Another two, pDA59 and pDA34, contained only 59 and 34 bp from
the right end, respectively. An additional plasmid, named pD10,
containing the 10 terminal bp from the right end, was obtained by
direct subcloning of a restriction fragment of plasmid pID13 in
plasmid pKK223-3 (not shown).
The DraI fragments containing g29 deleted sequences were
isolated from each clone and used as templates for the in vitro
initiation reaction. Fig. 2B shows that the DNA fragments 2,254
bp long from plasmids pIM46 and pIA12, respectively, were still
active (lanes b and c), at the same level as the 2,956 bp long
pID13 fragment containing the 73 terminal bp from the left 029
DNA end (lane a). A DNA fragment without 929 DNA sequences pro-
duced only a background level of p3-dAMP initiation complex (lane
d). The results were less clear for the right-end derivatives
pDA59, pDA34 and pDA10, as the initiation activity of the frag-
ments, 560, 500 and 755 bp long, respectively, was rather low and
it progressively decreased to the background level (results not
shown). The right-end series was completed by treatment of the
StuI-linearized plasmid pDA59 with exonuclease III and mung bean
nuclease (Fig. 3A). Six clones, mD40, mDA25, mDA22, mDA12, mD10
and mDA9, were selected, each one containing the number of
terminal bp from the right 929 DNA end indicated in its name. An
effect similar to that mentioned for the pD, series was observed
in the initiation reaction with the DraI fragments 560-530 bp
long from the mDA series, as shown in Fig. 3B, but, in this case,
the activity of clones mDA10 and mDA9 (lanes d and e) did not
seem to be significant relative to the background (lane f).
The in vitro replication assay was then carried out with all
DNA fragments containing the deletions described before to check
the results obtained in the initiation assay. The results on the
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Figure 3. Production and template activity of exonuclease III
deletions of plasmid pDA59.
A) The StuI-linearized plasmid pDf59 was digested with exo-
nuclease III and mung bean nuclease. The DNA was further digested
with SalI and the subfragment containing the partially deleted
sequence of the right end was isolated and inserted in phage M13
mpl9 DNA. 929 inserts are indicated with double line and the
products of the action of exonuclease III and mung bean nuclease
with discontinuous line. 7 , DraI sites. B) 3 ng of each DraI
fragment, about 530 bp long, containing deletions of the right929 DNA end, isolated from the M13 derivatives mDA25 (a), mDt22(b), mDA12 (c), mDA10 (d) or mDA9 (e), were used as templates in
an initiation assay with 25 ng of protein p2 and 42 ng of protein
p3. Four ng of the unspecific 692 bp long pID13/DraI fragment
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were used as control (f). C) 3 ng of each DraI fragment contai-
ning deletions of the right 029 DNA end, isolated from the M13
derivatives mDA22 (a,b), mDA12 (c,d) or mD10 (e,f) were used as
templates in a replication assay with 25 ng of protein p2, i-n the
presence (a,c,e) or in the absence (b,d,f) of 86 ng of protein
p3.
initiation activity of the deletion mutants at the left 029 DNA
end were confirmed (not shown). For the deletion mutants at the
right end (Fig. 3C), a low, but significant p3-dependent repli-
cation was observed with the DNA of clones mDA22 (lanes a and b)
and mDA12 (lanes c and d), but not with that of mD10 (lanes e
and f).
These results indicated that the minimal sequences active as
029 origins of replication were comprised within the terminal 12
RIGHT END ACTIVITY274
pID13 AAAGTA1--_yV______ _-AATAAGCTT +59
pDA59 AAAGTA---, ---TTCGACAAG +34
pDA34 AAAGTA -_____ ACCATTTCC +25
mDA25 AAAGTA_ >/___ACAACATAC +22
mDA 22 AAAGTA /_ ACAACA +12
mDA12 AAAGTAGGGTAC +
10
pDA10 AAAGTAGGGT __
7
pITR-A AAAGTAG
6
pITR-B AAAGTA
LEFT END 77
pIDl3 AAAGTA______A//.__ACCATGATC +
46
pL646 AAAGTA___--//---AATATCGAC +12
pIl12 AAAGTAAGCCCC. +
9
pITR-B AAAGTAAGC-_-
6
piTR-A AAAGTA -
Figure 4. Deletion map of the origins of replication of 029 DNA.
Only the ITR and the end-distal %29 DNA sequences are pre-
sented for those clones containing more than 12 bp from %29 DNA.
The sequences of both fragments of pITR (A and B) are compared to
each 029 DNA end. The template activity was tested in the
initition and replication assays as described in Materials and
Methods, and is indicated as positive (+) for initiation and
replication values from 50-100% or negative (-) for initiation
values <20% and replication values <5%.
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Figure 5. Site-directed mutagenesis at positions 2 or 3 of the
029 DNA ends. Template activity of the mutants.
A) The procedure described by Zoller and Smith (23) was fol-
lowed. Transformants were screened on nitrocellulose filters by
separate hybridizations with a radioactive probe of each oligo-
nucleotide, MS1 and MS2, at room temperature; the filters were
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washed at different temperatures up to 450C and 550C, respec-
tively, to detect the mutants from which clones R161 and H7 were
finally segregated. The autoradiography of one of the filters
showing two positive clones, in duplicate, is presented. Double-
line represents the cloned i29 sequences. The 6 bp long ITR
sequences, represented by striped double-line, are shown. The
target bases and the changes introduced are underlined. The
mutated left or right ITR sequences are indicated with an
asterisk. t , DraI sites. B) The initiation assay was carried out
using as templates: 4 ng of the left origin-containing fragments
isolated from the RsaI/DraI digestion of clones G7, with the
wild-type sequence (a), or R161, with the A-+C transversion at
position 2 (b), 8 ng of the analogous fragments from the DraI
digestion of clone G7, with the wild-type sequence (c), or from
the HpaI/DraI digestion of clone H7, with the A-+C transversion at
position 3 (d), 17 ng of a fragment without 929 sequences (e),
and 3 ng of the right origin-containing fragments isolated from
the DraI digestion of clone G7, with the wild-type sequence (f),
or from the HpaI/DraI digestion of clone H7, with the A+C trans-
version at position 3 (g). The conditions of the reactions were
those indicated in Fig. 3B.3Ihe label at the bottom of the lanes
corresponds to residual (a- P)dATP.
bp at each Y29 DNA end. A compilation of the mapping analysis is
shown in Fig. 4.
Point mutagenesis at the 929 DNA origins of replication. Two dif-
ferent strategies, site-directed and random mutagenesis, were
followed to obtain point mutations at the origins of replication,
depending on the bases selected as target.
The terminal 3 bp of each cloned 029 origin of replication
produced the DraI site used to release the Y29 sequences at the
ends of linear DNA fragments. Thus, mutations at any of the 3
terminal positions of one of the cloned origins must be conco-
mitant with another palindromic change at the other origin, and
both changes should generate a new restriction site replacing the
one lost. Attending to these requirements, there were only two
possible mutations at that region in both 029 DNA ends, an A4C
transversion at the 2nd or at the 3rd position, generating RsaI
or HpaI sites, respectively. The strategy depicted in Fig. 5A was
followed and mutants R161 and H7 were obtained, containing the
change A4C at the 2nd or the 3rd position, respectively. Figure
5B shows the result of an initiation reaction using as templates
the DNA fragments isolated from clone R161, mutated at the 2nd
position in the left 929 DNA end (lane b), and from clone H7,
mutated at the 3rd position in the left (lane d) or right (lane
g) 929 DNA ends. The initiation activity of these mutants, when
detectable, was very low, similar to the background of a DNA
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Figure 6. Random point mutagenesis along the i29 DNA origins of
replication. Template activity of the mutants.
A) The procedure described by Derbyshire et al. (24) was
followed. The 3'-end of the oligonucleotides was first ligated to
the PstI-linearized vector. The DNA was then converted to full
double-strand, cut with SmaI to produce blunt ends, and incubated
with ligase after 30-fold dilution to favour circularization.
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Double-line represents double-stranded DNA. The synthetic DNA is
represented with wavy line and the repaired strand with disconti-
nuous line. 7 , DraI sites. The XmaI site at the 5'-end of the
oligonucleotides was relevant for a different cloning strategy
not shown here. B) 31 ng of the DraI-digested DNAs of clones PM3
(a), PM5 (b), PM9 (c), PM12 (d), PM28 (e), PM31 (f), or PM46 (g),
were used as templates in a replication reaction as described in
Fig. 3C. The absence (-) or presence (+) of priming protein p3 in
each reaction is indicated. The position of the input DNA frag-
ments 1,626 and 522 bp long, containing the g29 left and right
origins of replication, respectively, is also indicated. Additio-
nal bands not coinciding with the input fragments are considered
to be caused by single-stranded intermediates of p29-specific
replication as judged by nuclease Sl sensitivity. The mutations
affecting the left origin in each clone are presented in Figure
7. Clone PM46 contains a wild-type right origin at the fragment
522 bp long.
fragment without Y29 DNA sequences (lane e) and much lower than
that of the control fragments carrying the wild-type sequences
(lanes a, c and f). Although the mutation at the 3rd position of
the left R29 DNA end did not seem to inactivate completely its
template activity in the initiation assay, the lack of activity
of the three mutated DNAs was further confirmed in replication
assays (results not shown). The right 929 DNA end with an A-C
mutation at the 2nd position, contained in R161 DNA, could not be
assayed. As it has been indicated, the release of the mutated 029
DNA ends from R161 DNA required treatment with RsaI, and there is
a target for this enzyme at position 10 in the right 029 DNA end,
inside the origin of replication.
Fig. 6A shows the saturation mutagenesis strategy followed
to obtain point mutants along the terminal 12 bp of both 029 DNA
ends. The DNA sequence of 55 transformants was determined and 14
of them, carrying point substitutions beyond position 3 at each
origin of replication of 929 DNA, were selected. Fig. 6B shows
the template activity of 7 out of these 14 selected clones. The
mutated DNAs were cut with DraI and directly assayed in the
replication reaction, without further isolation of the origin-
containing DNA fragments. The left origin was released in a DNA
fragment 1,626 bp long and the right one in a fragment 522 bp
long. As it can be seen, only the fragment 1,626 bp long became
labelled in the presence of priming protein p3, and it did so in
almost all mutants as efficiently as in a wild-type fragment (not
shown). Only in one clone of those shown in the Figure (PM31,
lane f) was the labelling markedly reduced, to about 20% of that
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1 2 3 4 5 6 7 8 9 10 11 12 ACTIVITY
Wt A A A G T A A G CC C C +
R161 C
H7 C
PM 31 T G +
PM4 C G +
PM22 A G +
PM3 G +
PM5 G +
PM9 G +
PM 12 A +
PM21 T A +
PM27 T G +
PM36 A G +
PM37 T +
PM42 G A +
PM46 T +
Figure 7 Point mutations at the left origin of replication of
929 DNA.
Only the bases different from those at the same position in
the wild-type sequence are shown. The template activity was
tested in the initiation and replication assays for clones Rl61
and H7, and only in the replication assay for all the others.
Symbols (+), (+/-) and (-) represent normal (replication values
from 80-100%), reduced (replication values from 20-50%) and
undetectable (initiation values <20% and replication values <5%)
activities, respectively.
of the other mutant or wild-type clones, as determined by densi-
tometry of the autoradiographs. Two more mutants out of the 14
assayed also showed a significant decrease of template activity
(see PM4 and PM22 in Fig. 7). The template activity of the
mutated right origin of replication could not be determined,
since the DNA fragments 522 bp long hardly incorporated any label
in the presence of protein p3, even if containing a wild-type
origin (lane g). This lack of template activity was shown to be
an effect of the small size of the right origin-containing frag-
ment. when a particular mpl8 derivative was used instead of the
mp19 ones, the wild-type right origin was released in the DraI
fragment 1,626 bp long and the wild-type left origin in the frag-
ment 522 bp long; again, only the larger fragment was active as
template (results not shown). We have previously reported a size
effect on the activity of p29-specific templates in the in vitro
initiation reaction (8,11).
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Fig. 7 shows a summary of the sequences of the different
point mutations introduced in the left origin of replication of
029 DNA and their effect on the in vitro template activity.
DISCUSSION
One particular feature common to all DNAs known to have a
terminal protein covalently linked is the presence of inverted
repeats at the ends of the molecule (30). Most of these DNAs,
which appear in a wide variety of prokaryotic and eukaryotic
organisms, have -100-600 bp long ITRs, so called "long" ITRs, as
compared to the 6-8 bp long highly homologous "short" ITRs found
in the DNAs of the p29-related bacteriophages of B. subtilis. For
the adenovirus system, the best studied one with a "long" ITR, it
has been already demonstrated that, although the repetition seems
to be somehow involved in the adenovirus multiplication cycle
(31), the sequences acting as DNA origins of replication are much
smaller than the whole ITR (32).
It had been thought that the 6 bp repeated at the ends of
029 DNA, as well as the short ITRs of the other phage DNAs, could
by themselves be the origins of replication. Our results with
plasmid pITR, containing not only the P29 ITRs, but also 3 and 1
additional bp from the left and right 929 DNA ends, respectively,
showed that this is not the case. In the 029 in vitro replication
system in the absence of the parental protein p3, although pITR
DNA showed a detectable template activity above the background,
it was not significant as compared with that of pID13 DNA, with
longer terminal sequences of 029 DNA. Therefore, it seems that
some bases beyond the ITRs are needed. With the aid of enzymati-
cally produced deletion derivatives of plasmid pID13 we have map-
ped their extent. Although a great number of different deletions
were not obtained for the left end of #29 DNA, the results
clearly indicate that the terminal 12 bp from the left end
present in pIA12 DNA has as much template activity as the 73 bp
present in pID13 DNA. The vector sequences flanking those 12 bp
do not seem to affect significantly this activity (results not
shown).
The template activity of the DNA fragments bearing a deleted
right end was always lower than that of the left end, most likely
due to their smaller size. The template activity of the deletions
at the right origin of replication contained in DraI fragments
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-530 bp long from the mDA series could be determined in the
replication assay only when the isolated fragments were tested
(Fig. 3C). When DraI restriction mixtures were used as templates
in the replication assay, it became difficult to detect the
specific labelling of origin-containing fragments about 500 bp
long (see Fig. 6B). It seems as if the DNA fragments present in
the restriction mixture compete for proteins p2 or p3, with a
decrease of the labelling of the smaller origin-containing frag-
ments. The size effect could also be related to the observed
gradual loss of template activity of the right 029 DNA end in
fragments from clone pDA59 through clone mDA12. It is possible
that additional signals located beyond position 12 at the right
929 DNA end can enhance the initiation of replication promoted by
the minimal origin. The lack of these signals would imply a
special sensitivity of the origin of replication to the size of
the DNA fragment, in the in vitro system.
The fact that the sequences at the left and right 029 DNA
ends are quite different beyond position 6 (Fig. 4), suggests
that the degree of sequence requirement at that distal region
is less strict than that at the end-proximal region. The results
obtained with the point mutants support this idea. Only two
mutations completely abolish the template activity of 029 DNA
ends, and both of them changed terminal bases, the 2nd or the 3rd
ones. For the left end, only 3 out of 14 mutations reduced the
template activity; all 3 were double changes, and 2 of them af-
fected the ITR, at positions 4 and 6, respectively, in addition
to the C at position 12. Most of the mutations affecting only the
distal half of the origin of replication did not have a signifi-
cant effect on its function. Although required as a part of the
origin, this region may not be recognized nucleotide by nucleo-
tide, but rather as a whole structure, disturbed only by some
double mutations such as the one in clone PM22, affecting posi-
tions 10 and 12 at the left origin. Clone mDA10, a deletion
derivative that can be considered as a double mutant at positions
11 and 12 at the right origin, was also inactive.
The 929 ITR sequence may represent, according to this data,
the "core" of each origin of replication, identical at both DNA
ends because most of the changes inside it, and specially any one
close to the first positions, would have been selected against.
As has been mentioned, the length of the ITR sequences at the DNA
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ends of p29-related phages is not the same, and in one of the
phages even bases inside the ITR are not homologous to that of
the others. However, in agreement with our results, the sequence
AAA is conserved at the very ends in all cases.
The results presented here indicate a direct involvement of
the "short" ITRs in the function of the origins of DNA replica-
tion, presumably as binding sites for the priming protein or for
a complex between the priming protein and the p29 DNA polymerase.
The "long" ITRs have been proposed to be involved in the repli-
cation of completely displaced single-strands of parental DNA by
facilitating the formation of panhandle structures with a double-
stranded DNA end (33). Such structures have not been observed in
the 029 group and they are not likely to be formed because of the
short length of their ITRs (34).
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